The Great Bio-Data Paradox: Why the Billion-Dollar Cali Fund Remains Empty

YEREVAN, ARMENIA — A decade after the international community first convened to address the equitable sharing of benefits derived from nature’s genetic blueprints, the global mechanism designed to funnel corporate profits back into conservation is facing a state of near-total paralysis. Despite the high-stakes negotiations at the United Nations biodiversity summit (COP17) which concluded in Yerevan, Armenia, on October 31, 2024, the "Cali Fund"—once hailed as a revolutionary financial bridge between the Global North and South—remains a largely symbolic gesture, holding less than $11,000 against a target of $1 billion per year.

The failure to reach a consensus on the operational mechanics of Digital Sequence Information (DSI) has forced a four-year deferral, pushing critical decisions to COP18 in 2028. This delay leaves a gaping hole in the funding required to meet the "30 by 30" goals of the Kunming-Montreal Global Biodiversity Framework, while companies continue to profit from the digitalized genetic data of plants, animals, and microbes sourced from biodiversity-rich developing nations.

Main Facts: A Mechanism in Limbo

The Cali Fund was established to rectify a modern loophole in international law: the transition of genetic resources from physical samples to digital data. While the 1993 Convention on Biological Diversity (CBD) and the 2014 Nagoya Protocol mandated benefit-sharing for physical biological material, they did not explicitly cover Digital Sequence Information (DSI). As biotechnology evolved, scientists began sequencing genomes and uploading them to open-access databases. Companies could then access this information to develop pharmaceuticals, cosmetics, and agricultural products without ever touching a physical plant or animal, thereby bypassing traditional benefit-sharing obligations.

At the heart of the current crisis are several unresolved questions that COP17 failed to answer:

  1. Mandatory vs. Voluntary: Which companies should be compelled to pay, and should the contribution remain voluntary?
  2. The Rate of Contribution: Should the fee be based on a percentage of revenue (0.1%) or a percentage of profit (1%)?
  3. The "Certificate" Problem: How can the UN provide "legal certainty" to companies that their payments immunize them from future claims by individual nations?
  4. Database Accountability: How can public databases, largely based in the Global North, be held accountable to the sovereign rights of the Global South?

As of November 10, 2026, the fund’s official ledger at the UN Multi-Partner Trust Fund Office recorded a total of $10,588. This sum represents the contributions of five small-scale enterprises, while the multi-billion-dollar pharmaceutical and agribusiness giants—the primary targets of the fund—have remained on the sidelines.

Open genetic data and unclear rules keep biodiversity fund largely empty

Chronology: The Decade-Long Path to Stagnation

The journey toward a DSI benefit-sharing mechanism has been marked by incremental progress and significant diplomatic friction:

  • December 2016 (COP13, Cancún): Countries officially recognize that the use of DSI might impact the CBD’s objectives. A study is commissioned to explore the implications of digital data on conservation and equity.
  • 2018–2021: Intense lobbying occurs. The European Union and the United States (a non-party to the CBD) argue that open access to data is a public good and should not be restricted by "access and benefit-sharing" (ABS) rules. Developing nations, led by the African Group, India, and Brazil, argue that open access without benefit-sharing is "digital biopiracy."
  • December 2022 (COP15, Montreal): A breakthrough occurs. Parties agree that benefits from DSI use should be shared fairly and equitably through a global fund.
  • October 2024 (COP16, Cali): The "Cali Fund" is officially named and launched. It establishes a "multilateral mechanism" for benefit-sharing, moving away from the bilateral (country-to-country) model of the Nagoya Protocol.
  • October 2024 (COP17, Yerevan): Expected to be the "implementation COP," the summit ends in a stalemate. Major decisions regarding the "threshold" for payments and the methodology for fund allocation are deferred to 2028.

Supporting Data: The Economic Gap

The discrepancy between the potential of the Cali Fund and its current reality is stark. According to a June 2026 study by the London School of Economics (LSE), the infrastructure for a billion-dollar fund already exists in the global market.

The Potential Revenue

The LSE researchers identified 21,690 companies across 100 countries that meet the size and sector criteria (pharmaceuticals, biotechnology, cosmetics, and plant breeding) to contribute to the fund.

  • Maximum Estimate: If all eligible companies contributed at the suggested rates, the fund could generate $3.65 billion annually.
  • Conservative Estimate: Accounting for varying levels of DSI reliance and market participation, a more realistic target was set at $929 million annually.

The Current Reality

Despite these projections, the fund’s growth has been glacial:

  • First Contribution (2025): $1,000 from TierraViva AI, a small UK-based artificial intelligence firm.
  • Total as of late 2026: $10,588.
  • Participation Rate: 0.02% of the identified eligible companies.

The data reveals that the "voluntary" nature of the current agreement is a primary hurdle. Large corporations are hesitant to pay into a fund that lacks a standardized global enforcement mechanism, fearing that they may be "paying twice"—once to the Cali Fund and again if a specific country decides to sue them under national laws.

Open genetic data and unclear rules keep biodiversity fund largely empty

Official Responses: A Divided Worldview

The deadlock at COP17 has drawn sharp criticism and defensive maneuvers from various stakeholders.

The Civil Society and Academic Perspective

Nithin Ramakrishnan, a senior researcher at the Third World Network (TWN), highlighted the lack of preparation as a fatal flaw. "Unfortunately, the preparations between the two COPs did not reach a point where COP17 could take a final call," he noted. "The goalpost has now shifted to COP18, leaving the interim measures as the only standing rules."

Siva Thambisetty, an associate professor at the London School of Economics who helped design the threshold rules, expressed frustration over the focus on "allocation methodology." She remarked, "It seems absurd to spend so much time on how to share the money when there is hardly any money to share." She argued that two key elements are missing: a public awareness campaign and state-level pressure on companies to contribute.

The Voice of the Global South

Gustavo Soldati, a professor and member of Brazil’s National Biodiversity Commission (CONABIO), emphasized the geopolitical imbalance. He pointed out that major databases like GenBank are based in the U.S., a country not legally bound by the CBD. "How can we ensure that these infrastructures respect the decisions adopted under the Convention?" he asked, warning that without reliable data on the origin of sequences, "biodiversity-rich countries risk being underrepresented in the allocation process."

The Industry Response

Conversely, the International Chamber of Commerce (ICC) and pharmaceutical trade lobbies have called for a "radical rethink." Their primary demand is "legal certainty." Industry representatives argue that they will only contribute if they receive a certificate that guarantees "compliance" across all 196 member nations of the CBD. Without such a guarantee, they view the Cali Fund as an additional, unreciprocated tax.

Open genetic data and unclear rules keep biodiversity fund largely empty

Implications: Stewardship and the Future of Conservation

The failure to operationalize the Cali Fund has profound implications for global conservation efforts and the rights of Indigenous peoples.

1. The Erosion of Trust

The Cali Fund was promised as a way to recognize the "stewardship" of Indigenous peoples and local communities (IPLCs). Half of the fund’s proceeds are earmarked for these groups, regardless of whether a specific sequence can be traced to their land. By failing to populate the fund, the international community risks breaking a fundamental promise made in Montreal and Cali, potentially discouraging local communities from participating in conservation efforts.

2. The Threat to "Open Science"

The debate over DSI is often framed as a conflict between "Open Science" and "Benefit-Sharing." However, as Gustavo Soldati noted, the current system is only "half-open." While the data flows freely from the Global South to Northern laboratories, the financial benefits are locked behind corporate patent walls. If the Cali Fund continues to fail, developing nations may begin to restrict access to their physical genetic resources or impose stricter national digital regulations, effectively ending the era of open-access genomic research.

3. The Biopiracy Risk

Without a transparent and accountable database system, the risk of "biopiracy"—the commercial exploitation of biological resources without compensation—remains high. Currently, only 16% of sequences in major databases carry information about their country of origin. This lack of traceability makes it nearly impossible to ensure that the countries providing the raw genetic data receive any portion of the eventual profits.

4. Strategic Delay

By deferring the decision to 2028, the global community has effectively granted industry four more years of "business as usual." For many advocates in the Global South, this delay is seen not as a logistical necessity, but as a strategic win for Northern industrial interests who benefit from the status quo of free data.

Open genetic data and unclear rules keep biodiversity fund largely empty

As the world looks toward COP18, the central question remains: Can a voluntary fund ever bridge a billion-dollar gap, or will the international community be forced to adopt legally binding mandates to ensure that those who profit from nature also pay for its protection? For now, the Cali Fund stands as a stark reminder of the distance between diplomatic rhetoric and financial reality.

Lina Hope

Penulis aktif di HypePress yang membagikan konten inspiratif, informasi terkini, dan gaya hidup untuk generasi muda.

Artikel Bermanfaat dan Menghibur Lainnya